Yuya Aoto

Clinical and Genetic Insights Into Isolated Proteinuria With CUBN Variants

Nana Sakakibara, 菜々 榊原, ナナ サカキバラ, Shinya Ishiko et autres

Clinical and Genetic Insights Into Isolated Proteinuria With CUBN Variants

Nana Sakakibara, Shinya Ishiko, Yu Tanaka, Yuta Inoki et autres

jp (code pays fourni par la source)

Relationship of high intensity sumo training and body mass index in student sumo wrestler

Yuya Aoto, Oka M, Takeshi Sato, M. Nakajima et autres

jp (code pays fourni par la source)

Clinical use of the VNtyper-Kestrel pipeline for MUC1 variant detection in autosomal-dominant tubulointerstitial kidney disease

China Nagano, Naoya Morisada, Yuta Inoki, Yu Tanaka et autres

jp (code pays fourni par la source)

Comprehensive Splice Pattern Analysis for Previously Reported OCRL Splicing Variants and Their Phenotypic Contributions

Rini Rossanti, Eri Okada, Nana Sakakibara, Ryota Suzuki et autres

id, jp (code pays fourni par la source)

COL4A5 Intronic Variants at Third to Fifth Nucleotides Cause Alport Syndrome

Hideaki Kitakado, Tomoko Horinouchi, Shuhei Aoyama, Yuka Kimura et autres

jp, id (code pays fourni par la source)

Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome

Ryota Suzuki, Nana Sakakibara, Sae Murakami, Yuta Ichikawa et autres

jp (code pays fourni par la source)

Aberrant Splicing Caused by Intronic Variants Positioned at Third to Fifth Nucleotides in COL4A5

Hideaki Kitakado, Yuya Aoto, Eri Okada, Yuta Ichikawa et autres

jp (code pays fourni par la source)

Management of children with obesity at local hospital and impact of COVID-19 pandemic

Takeshi Ninchoji, Yuya Aoto, Natsuki Momo, Jun Maruyama et autres

jp (code pays fourni par la source)

Long-term outcome of combination therapy with corticosteroids, mizoribine and RAS inhibitors as initial therapy for severe childhood IgA vasculitis with nephritis

Sadayuki Nagai, Tomoko Horinouchi, Takeshi Ninchoji, Yuta Ichikawa et autres

jp (code pays fourni par la source)

All reported non-canonical splice site variants in GLA cause aberrant splicing

Eri Okada, Tomoko Horinouchi, Tomohiko Yamamura, Yuya Aoto et autres

jp (code pays fourni par la source)

Corrigendum to “Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease”Kidney International Reports, Volume 7, Issue 4, April 2022, Pages 857-866.

Eri Okada, Naoya Morisada, Tomoko Horinouchi, Hideki Fujii et autres

jp (code pays fourni par la source)